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Abstract
Background: Giant cell arteritis typically involves the temporal arteries, but can involve other cranial arteries.
Temporal artery biopsy is the mainstay for the diagnosis of giant cell arteritis; however, biopsy may be problematic
if giant cell arteritis involves other cranial arteries that are inaccessible for sampling. In these situations, magnetic
resonance angiography is a useful, non-invasive adjunctive method in the diagnosis of giant cell arteritis. In this
case report, we describe a case of giant cell arteritis involving only the occipital artery which was revealed by
magnetic resonance angiography.
Case presentation: A 67-year-old Caucasian man was admitted to our hospital with a 4-week history of malaise,
fever, and mild occipital headaches. There were no other positive findings on physical examination. Laboratory
studies were remarkable for normocytic anemia, raised inflammatory markers, and mildly deranged liver function
tests. To exclude intracranial pathology, he underwent a cranial magnetic resonance imaging with gadolinium,
which demonstrated a thickened wall and mural enhancement of his right occipital artery, consistent with giant
cell arteritis. His temporal arteries were normal. His occipital arteries were not accessible for biopsy and he was
commenced on high-dose prednisolone (60 mg daily). His symptoms resolved completely after a week of
glucocorticoid steroid treatment and he was well on 5 mg of prednisolone once a day on follow-up.
Conclusion: While magnetic resonance angiography may not replace the need for biopsy, it may have a diagnostic
role in suspected giant cell arteritis, such as when the involved arteries are inaccessible for biopsy.
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Background
Giant cell arteritis (GCA) is a chronic inflammatory
disorder characterized by granulomatous infiltrates affect-
ing the large and medium-sized vessels. It is closely related
to polymyalgia rheumatica (PMR) [1]. GCA occurs
predominantly in females, with a mean age at diagnosis of
72 years [2] and is the most common chronic vasculitis of
medium and large arteries in populations with predomin-
antly Northern European ancestry. The diagnostic criteria
for GCA according to American College of Rheumatology
(ACR), require the fulfilment of at least three of the
following five criteria: (i) age more than 50 years, (ii) new
headache, (iii) superficial temporal artery tenderness or
decreased pulsation, (iv) elevated erythrocyte sedimenta-
tion rate (ESR) of more than 50 mm/hour using the
Westergren method, and (v) abnormal findings on
temporal artery biopsy [3]. GCA can be a diagnostic
challenge for physicians due to the wide variation of
presentations, false negative histology, absence of
potential biopsy sites, or lack of cranial symptoms.
Furthermore, cranial arteries other than the temporal
artery are involved in more than half of GCA cases
[1]. As a result, symptoms are often atypical and
may include fever, general malaise and weight loss.
We report a case of GCA with only right occipital
artery involvement diagnosed by magnetic resonance
angiography (MRA).
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Case presentation
A 67-year-old Caucasian man presented with a 4-week
history of general malaise, mild occipital headache, and
fever. He has a past medical history of hypercholesterol-
emia and a stable right acoustic neuroma under observa-
tion. He described no visual disturbance, jaw claudication,
arthralgia, or weight loss.
On physical examination, he was febrile with temperature
of 38 °C. He had no active synovitis or rash. His temporal
arteries were not palpable; a cranial nerve and funduscopic
examination was normal. There was no lymphadenopathy
or hepatosplenomegaly. The rest of the physical examin-
ation was unremarkable.
Laboratory investigations showed mild normocytic
anemia, raised inflammatory markers, and mild deranged
liver function test (Table 1). Renal function and electro-
lytes were within normal reference ranges. Multiple blood
and urine cultures were negative. Further investigations
including vasculitic screen, complete autoimmune screen,
infective viral screen, and malignant screen were either
negative or in the normal range (Table 1). Computed
tomography (CT) of his neck, thorax, abdomen and pelvis
were negative for lymphadenopathy, mass, abscess, and
infective focus. A bone morrow biopsy and aspirate
showed mild reactive plasmacytosis and the culture was
negative for tuberculosis.
In the setting of fever, headache, and raised inflamma-
tory markers, our patient underwent a cranial 3.0 tesla
(3T) magnetic resonance imaging (MRI) with gadolinium,
which showed a thickened wall and mural enhancement
of his right occipital artery consistent with GCA (Fig. 1).
His temporal arteries were normal bilaterally. After
consultation with vascular surgeons, there was no
potential biopsy site to enable histopathological con-
firmation. A diagnosis of GCA was considered and
he was started on oral prednisolone (60 mg daily).
He became afebrile on the second day of treatment
and all symptoms resolved within 1 week. On follow-up,
he has been well and the prednisolone dose has been
gradually tapered down to 5 mg daily. Six weeks after the
glucocorticoid steroid treatment, he underwent an 18-
flurodeoxyglucose (18FDG) positron emission tomography
(PET) scan, which revealed complete resolution of occipi-
tal GCA and no evidence of other vasculitis.
Table 1 Laboratory, serological, and immunological
investigation results
Variables Results Normal reference
range
Hemoglobin 116 g/L 135–175 g/L
Red blood cells 3.95×1012 L 4.50–6.00×1012 L
Mean cell volume 91.6 fl 80.0–98.0 fl
Platelet count 484×109/L 150–450×109 L
White cell count 6.61×109/L 4.00–11.0×109/L
Neutrophils 4.83×109/L 1.80–7.50×109/L
Gamma-glutamyl transpeptidase 189 U/L <60 U/L
Alkaline phosphatase 172 U/L 30–110 U/L
Alanine aminotransferase 165 U/L <55 U/L
Aspartate aminotransferase 65 U/L <45 U/L
Lactate dehydrogenase 167U/L 110–230 U/L
Sodium 139 mmol/L 137–145 mmol/L
Potassium 4.2 mmol/L 3.5–4.9 mmol/L
Urea 4.0 mmol/L 2.7–8.0 mmol/L
Creatinine 53 μmol/L 50–120 μmol/L
Erythrocyte sedimentation rate (ESR) 96 mm/h 1–13 mm/h
C-reactive protein (CRP) 400 mg/L <10 mg/L
Antinuclear antibody Negative
Extractable nuclear antibody Negative
Anti-neutrophil cytoplasmic Negative
Hepatitis B and C serology Negative
Liver, kidney mitochondrial antibody Negative
Smooth muscle antibody Negative
Anti-mitochondrial antibody Negative
Serum electrophoresis No paraprotein
Fig. 1 High-resolution T1 fat-saturated magnetic resonance sequences
before (a) and after (b) intravenous gadolinium injection demonstrates
mural thickening and enhancement in the right occipital artery (dashed
arrow). Solid arrow denotes the less-affected left occipital artery
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Discussion
Other cranial arteries can be involved in GCA apart
from the temporal arteries [4]. Branches of the external
carotid artery, including the posterior ciliary arteries that
supply the optic nerve and primary and secondary
branches of the aorta are often affected. GCA of the
lower extremity arteries and mesenteric arteries is ex-
tremely rare, while intracranial arteries are essentially
spared [5]. The diagnosis of GCA is usually confirmed
by temporal artery biopsy with histopathology demon-
strating panarteritis with mononuclear infiltrates pene-
trating all layers of the arterial wall [1]. However, this
can pose a problem in cases where the temporal artery is
spared. Furthermore, the inflammation of the temporal
artery in GCA can be segmental making the diagnosis of
GCA challenging even when the affected artery is
accessible for biopsy. An estimate of the actual sensi-
tivity of unilateral temporal artery biopsy is between
69 and 95 % [6]. As a result, there is a growing inter-
est in using radiological imaging in the investigation
of patients with suspected GCA [7].
High resolution MRI with gadolinium is a useful non-
invasive adjunctive method in diagnosis of GCA. High-
resolution MRI in particular allows detailed assessment
of the major superficial cranial arteries, and administra-
tion of gadolinium allowing detection of arterial wall
thickening and periadventitial enhancement suggestive
of mural inflammation. These abnormalities are likely to
represent the early vascular inflammation that precedes
the development of luminal changes and can be used as
a guide to estimating disease activity [8]. Single-center
and multi-center trials evaluating MRI of the superficial
cranial arteries (superficial temporal and occipital arter-
ies) have yielded an overall sensitivity of between 78 and
89 % and specificity between 90 and 92 % for the diag-
nosis of GCA [7, 9]. A further role for MRI in following
up of GCA response to treatment and monitoring for
recurrent disease activity has also been proposed [10].
One case report and a small study have suggested that
high resolution contrast-enhanced, black-blood T1-
weighted images with fat suppression might be useful for
the diagnosis of intracranial arteritis [11, 12]. This may
allow invasive procedures to be replaced, such as conven-
tional angiography and/or brain biopsies. However, the
role of black-blood T1-weighted images in diagnosing
extracranial arteritis has not been evaluated. Further stud-
ies are needed to confirm these initial promising results.
Conventional angiography and CT angiography can also
document large vessel involvement in GCA [13], although
the risks associated with radiation exposure and iodinated
contrast media may limit scanning in patients who are
allergic to contrast or have renal impairment. Sono-
graphic features such as a hypoechoic periluminal halo
have been shown to have a high specificity for GCA on
meta-analysis, but its sensitivity and specificity values
have not been compared directly with MRI [14, 15].
More advanced disease may be seen sonographically as
vascular stenosis or occlusion. Recent literature identi-
fies 18FDG PET scans as well suited for the demonstra-
tion of GCA in arteries exceeding 4 mm in diameter
[16]. While not currently felt suitable to replace the
need for biopsy, a potential role has been suggested for
MRA or 18FDG PET scan in the diagnosis of atypical
GCA, where conventional clinical features and temporal
artery biopsy are non-contributory, or for follow-up after
corticosteroid therapy.
Conclusions
In summary, atypical cases of GCA such as that presented
here pose a diagnostic dilemma to the clinician due to the
variable and nonspecific nature of patient presentation.
Although clinical features may be suggestive, inability
to obtain histopathological confirmation can limit diag-
nostic certainty. The increasing sensitivity and spe-
cificity of high-resolution MRI not only allows more
confident diagnosis of these atypical cases but may even
play a role in monitoring for response to treatment or
recurrent disease.
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